EP0349594A4 - Recombinant baculovirus occlusion bodies in vaccines and biological insecticides - Google Patents
Recombinant baculovirus occlusion bodies in vaccines and biological insecticidesInfo
- Publication number
- EP0349594A4 EP0349594A4 EP19880904294 EP88904294A EP0349594A4 EP 0349594 A4 EP0349594 A4 EP 0349594A4 EP 19880904294 EP19880904294 EP 19880904294 EP 88904294 A EP88904294 A EP 88904294A EP 0349594 A4 EP0349594 A4 EP 0349594A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- vaccines
- recombinant baculovirus
- biological insecticides
- occlusion bodies
- baculovirus occlusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002917 insecticide Substances 0.000 title 1
- 241000701447 unidentified baculovirus Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2649887A | 1987-03-16 | 1987-03-16 | |
US2649987A | 1987-03-16 | 1987-03-16 | |
US26499 | 1987-03-16 | ||
US07/153,736 US4870023A (en) | 1987-03-16 | 1988-02-08 | Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
US153736 | 1988-02-08 | ||
US26498 | 2004-12-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0349594A1 EP0349594A1 (en) | 1990-01-10 |
EP0349594A4 true EP0349594A4 (en) | 1990-09-26 |
Family
ID=27362785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19880904294 Withdrawn EP0349594A4 (en) | 1987-03-16 | 1988-03-02 | Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0349594A4 (en) |
JP (1) | JPH02502876A (en) |
AU (1) | AU1717688A (en) |
WO (1) | WO1988007082A1 (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2631974B1 (en) * | 1988-05-31 | 1992-12-11 | Agronomique Inst Nat Rech | MODIFIED BACULOVIRUS, ITS PREPARATION METHOD AND ITS APPLICATION AS A GENE EXPRESSION VECTOR |
US5145775A (en) * | 1989-02-28 | 1992-09-08 | Research Association For Biotechnology Of Agricultural Chemicals | Polyhedrin gene and genetic engineering thereof |
NZ243851A (en) * | 1991-08-05 | 1995-02-24 | Commw Scient Ind Res Org | Recombinant viruses and their use in biological insecticides |
US5762939A (en) * | 1993-09-13 | 1998-06-09 | Mg-Pmc, Llc | Method for producing influenza hemagglutinin multivalent vaccines using baculovirus |
EP2374894B1 (en) * | 1993-09-13 | 2014-09-17 | Protein Sciences Corporation | A method for producing influenza hemagglutinin multivalent vaccines |
FR2761994B1 (en) | 1997-04-11 | 1999-06-18 | Centre Nat Rech Scient | PREPARATION OF MEMBRANE RECEPTORS FROM EXTRACELLULAR BACULOVIRUSES |
KR100264953B1 (en) * | 1998-04-03 | 2001-03-02 | 박현우 | Recombinant baculovirus, process for preparing thereof and microbial insecticides containing same |
WO2002036785A1 (en) * | 2000-10-30 | 2002-05-10 | Protein Crystal Co., Ltd. | Protein complexes and process for producing the same |
BRPI0507169A (en) | 2004-02-02 | 2007-06-26 | Ambrx Inc | modified human growth hormone polypeptides and their uses |
KR20070034512A (en) | 2004-06-18 | 2007-03-28 | 암브룩스, 인코포레이티드 | New Antigen-Binding Polypeptides and Uses thereof |
CA2594561C (en) | 2004-12-22 | 2014-12-23 | Ambrx, Inc. | Formulations of human growth hormone comprising a non-naturally encoded amino acid |
EP2399893B1 (en) | 2004-12-22 | 2018-08-15 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
CA2594557C (en) | 2004-12-22 | 2016-04-26 | Ambrx, Inc. | Modified human growth hormone |
WO2006068802A2 (en) | 2004-12-22 | 2006-06-29 | Ambrx, Inc. | COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF |
AU2005323106B2 (en) | 2004-12-22 | 2010-07-29 | Ambrx, Inc. | Methods for expression and purification of recombinant human growth hormone |
WO2006133089A2 (en) | 2005-06-03 | 2006-12-14 | Ambrx, Inc. | Improved human interferon molecules and their uses |
CN101454461A (en) | 2005-11-16 | 2009-06-10 | Ambrx公司 | Methods and compositions comprising non-natural amino acids |
KR20090051227A (en) | 2006-09-08 | 2009-05-21 | 암브룩스, 인코포레이티드 | Hybrid suppressor trna for vertebrate cells |
CN106008699A (en) | 2006-09-08 | 2016-10-12 | Ambrx公司 | Modified human plasma polypeptide or Fc scaffolds and their uses |
JP5451390B2 (en) | 2006-09-08 | 2014-03-26 | アンブルックス,インコーポレイテッド | Transcription of suppressor TRNA in vertebrate cells |
KR101476472B1 (en) | 2007-03-30 | 2015-01-05 | 암브룩스, 인코포레이티드 | Modified fgf-21 polypeptides and their uses |
MX2009011870A (en) | 2007-05-02 | 2009-11-12 | Ambrx Inc | Modified interferon beta polypeptides and their uses. |
ES2632504T3 (en) | 2007-11-20 | 2017-09-13 | Ambrx, Inc. | Modified insulin polypeptides and their uses |
NZ602170A (en) | 2008-02-08 | 2014-03-28 | Ambrx Inc | Modified leptin polypeptides and their uses |
JP5680534B2 (en) | 2008-07-23 | 2015-03-04 | イーライ リリー アンド カンパニー | Modified bovine G-CSF polypeptides and their use |
MX2011003272A (en) | 2008-09-26 | 2011-04-28 | Ambrx Inc | Modified animal erythropoietin polypeptides and their uses. |
ES2660000T3 (en) | 2008-09-26 | 2018-03-20 | Ambrx, Inc. | Vaccines and microorganisms dependent on the replication of unnatural amino acids |
JP2013515080A (en) | 2009-12-21 | 2013-05-02 | アンブルックス,インコーポレイテッド | Modified bovine somatotropin polypeptides and their use |
EP2805965A1 (en) | 2009-12-21 | 2014-11-26 | Ambrx, Inc. | Modified porcine somatotropin polypeptides and their uses |
MX2010005637A (en) * | 2010-05-21 | 2011-11-24 | Univ Mexico Nacional Autonoma | Modified polyhedrin, and polyhedras and biotechnological products obtained from same. |
EP2588118B8 (en) * | 2010-06-23 | 2017-06-07 | Monash University | Constrained immunogenic compositions and uses therefor |
US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
ES2972902T3 (en) | 2010-08-17 | 2024-06-17 | Ambrx Inc | Modified relaxin polypeptides and their uses |
TWI480288B (en) | 2010-09-23 | 2015-04-11 | Lilly Co Eli | Formulations for bovine granulocyte colony stimulating factor and variants thereof |
JP5980947B2 (en) * | 2012-11-22 | 2016-08-31 | 旭化成メディカル株式会社 | Production method of parvovirus with high infectivity |
AU2015335603B2 (en) | 2014-10-24 | 2020-04-30 | Bristol-Myers Squibb Company | Modified FGF-21 polypeptides and uses thereof |
CN106701826B (en) * | 2015-11-13 | 2021-04-20 | 中国科学院武汉病毒研究所 | Recombinant plasmid capable of being used for packaging large amount of exogenous protein, construction method and application |
AU2018219283B2 (en) | 2017-02-08 | 2022-05-19 | Bristol-Myers Squibb Company | Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0127839A2 (en) * | 1983-05-27 | 1984-12-12 | THE TEXAS A&M UNIVERSITY SYSTEM | Method for producing a recombinant baculovirus expression vector |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4745051A (en) * | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
-
1988
- 1988-03-02 JP JP63504028A patent/JPH02502876A/en active Pending
- 1988-03-02 AU AU17176/88A patent/AU1717688A/en not_active Abandoned
- 1988-03-02 WO PCT/US1988/000631 patent/WO1988007082A1/en not_active Application Discontinuation
- 1988-03-02 EP EP19880904294 patent/EP0349594A4/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0127839A2 (en) * | 1983-05-27 | 1984-12-12 | THE TEXAS A&M UNIVERSITY SYSTEM | Method for producing a recombinant baculovirus expression vector |
Non-Patent Citations (3)
Title |
---|
EMBO JOURNAL, vol. 5, no. 6, 1986, pages 1359-1365, IRL Press Ltd, Oxford, GB; K. KURODA et al.: "Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector" * |
PROTEIN ENGINEERING, vol. 1, no. 4, August/September 1987, pages 359-366, IRL Press Ltd, Oxford, GB; V.C. EMERY et al.: "The development of multiple expression vectors for high level synthesis of eukaryotic proteins: expression of LCMV-N and AcNPV polyhedrin protein by a recombinant baculovirus" * |
See also references of WO8807082A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP0349594A1 (en) | 1990-01-10 |
JPH02502876A (en) | 1990-09-13 |
WO1988007082A1 (en) | 1988-09-22 |
AU1717688A (en) | 1988-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0349594A4 (en) | Recombinant baculovirus occlusion bodies in vaccines and biological insecticides | |
GB2201596B (en) | N-cyanoisothioureas and use thereof in pest control | |
IL94478A0 (en) | Tines structure in clinical applicator | |
IL90489A0 (en) | Recombinant coccidiosis vaccines and their preparation | |
PL271962A1 (en) | Insecticide and/or acaricide | |
OA09736A (en) | "Human interleukin-3 and muteins thereof". | |
EP0351314A3 (en) | Medical material and medical implement | |
GB9022368D0 (en) | Materials useful in human and veterinary medicine | |
EP0340333A3 (en) | Novel physiologically active polypeptide and pharmaceutical composition | |
IL90690A0 (en) | Tissue equivalents and their preparation | |
IL102704A0 (en) | Dna coding for human serum albumin and its use | |
EP0304802A3 (en) | Pharmaceutical composition and the use thereof | |
AP9000161A0 (en) | Insecticidal treatment and composition therefor | |
EP0433961A3 (en) | Medical device with oligodynamic active material | |
IL81895A0 (en) | N-pyridyloxyphenyl-isothioureas,their preparation and their use in pest control | |
EP0435199A3 (en) | Acrylic gel material and acrylic gel preparation | |
ZA902401B (en) | Phytosanitary preparation and use thereof | |
IL112075A0 (en) | Recombinant human thymopoietin proteins, their preparation and their medicinal use | |
EG18920A (en) | N - benzoyl - n'- 2,5 dihalo - 4 - perefluoroalko-xyphenylureas, their preparation and use in the control of pests | |
NZ227594A (en) | Human interleukin-1alpha and preparations thereof | |
JPS6425796A (en) | Insulin bonding peptide and its use | |
GB8920304D0 (en) | Fr901375 substance and preparation thereof | |
EG18799A (en) | Phenylthioureas, phenylisothioureas and phenylcarbodumides their preparation and use in the control of pests | |
GB9014503D0 (en) | Improvements in or relating to medical syringes | |
GB8918370D0 (en) | Material for use in biological cryoprotection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19890914 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19900808 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19901016 |